Eli Lilly

A framework for telling whether a secondary offering funds real growth or just lets insiders cash out — with the filings, ratios, and red flags that separate the two.

A same-store sales beat can mask real trouble. Here's how to split comps into traffic and ticket — and the mix patterns that signal a business is quietly breaking.

Companies love to promise SG&A discipline. Here's a framework to separate real operating leverage from one-time accounting noise — and which line items actually matter.

The top 10 names now drive most of the S&P 500's return. Here's how to measure that concentration, what equal-weight tells you, and how to think about diversification.

You can't predict a Phase 3 readout. But you can size the position so the answer doesn't matter — here's the framework prosumer investors actually need.

How to read short interest, days-to-cover, and borrow costs as signal — not as a squeeze setup. A framework for what each metric tells you, and what it doesn't.